Discover trends, market shifts, and competitive outlooks for the ankylosing spondylitis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Ankylosing Spondylitis Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there has been a substantial surge in the size of the ankylosing spondylitis market. The growth is predicted to increase from $5.9 billion in the year 2024 to $6.36 billion by the end of 2025, reflecting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the historic period include the discovery of hla-b27, advancement in biologic treatments, approaches to pain management, increased patient advocacy and awareness, and the use of NSAIDS and disease-modifying drugs.

Expectations are high for robust expansion in the ankylosing spondylitis market size in the ensuing years. The market is anticipated to balloon to $8.71 billion by 2029, with a compounded annual growth rate (CAGR) of 8.2%. The upswing during the forecast period can be ascribed to factors including the utilization of personalized medicine, the emergence of novel biologics, early interventions and screenings, management of lifestyle and diet, and the use of telemedicine and remote monitoring. Notable trends to watch for during the forecast period encompass the availability of biosimilars, specialized pain therapies, heightened emphasis on patient-reported outcomes (PROs), community-based support programs, and exploration of regenerative medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Ankylosing Spondylitis Market?

The projected surge in the aging population is anticipated to drive the expansion of the ankylosing spondylitis market. The reference to the geriatric population signifies a rise in the percentage of older individuals resulting from alterations in a population’s age makeup. This demographic transformation has amplified the count and ratio of individuals above 60 years of age. Treatments and medications for ankylosing spondylitis aid in enhancing mobility and handling pain in older people with this condition. For example, in January 2023, estimates from the United Nations Department of Economic and Social Affairs (UN DESA), a department of the US-based UN Secretariat, predicted that the worldwide population of people aged 65 and above is poised to more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. Hence, the escalation in the geriatric population is fuelling the growth of the ankylosing spondylitis market.

Which Key Market Segments Comprise the Ankylosing Spondylitis Market and Drive Its Revenue Growth?

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route Of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors

4) By Steroids: Oral Steroids, Injectable Steroids

5) By Physical Therapies: Physiotherapy, Exercise Programs

6) By Surgery: Joint Replacement Surgery, Spinal Surgery

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp

Which Areas Are Leading Regions in the Ankylosing Spondylitis Market Expansion Across the Globe?

North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theAnkylosing Spondylitis Market Direction?

The evolution of therapeutic solutions represents a prominent trend emerging in the ankylosing spondylitis market. Companies within this sector are pioneering new therapies to maintain their market standing. For instance, in April 2022, the U.S.-based biopharmaceutical firm, AbbVie Inc., declared the approval of RINVOQ by the U.S. Food and Drug Administration (FDA) for treating adults diagnosed with active ankylosing spondylitis (AS). This paves the way for a new orally administered treatment possibility for patients unresponsive to TNF blockers, demonstrating significant amelioration in symptoms like backache and physical functioning. The product’s prompt effectiveness and safety profile, determined through clinical trials, render it a pivotal advancement in the management of this chronic inflammatory ailment, thereby enhancing the array of therapeutic options accessible to patients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

How Is the Ankylosing Spondylitis Market Conceptually Defined?

Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model